![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » DynamiCare’s Digital Smoking Treatment Designated an FDA Breakthrough Device
DynamiCare’s Digital Smoking Treatment Designated an FDA Breakthrough Device
The FDA has designated Boston, Mass.-based DynamiCare Health’s DCH-001 prescription-only anti-smoking therapeutic software to be a Breakthrough Device.
The software is intended to treat tobacco use disorder to prevent complications in pregnancy and childbirth.
It is based on a motivational incentives approach invented by Stephen Higgins of the University of Vermont. In a published study, the university’s researchers found that pregnant women treated with the DCH-001 digital therapy were 2.8 times more likely to quit smoking by the end of their pregnancy compared to those given the usual care.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct